Pelion Pharma II -Covid-19 response
One of 10,000+ projects Taiyo tracks in Regional.
Source: European Bank for Reconstruction and Development (EBRD)
Provision of emergency short-term liquidity line in the amount of PLN 110 million (c. EUR 24 million) that will allow KIPF ("the company", "client") to actively manage working capital needs across business lines in light of increased sales volatility caused by the Covid-19 outbreak.
- Status
- Closed
- Sector
- Manufacturing (Industrial), Residential, Commercial, Government
- Location
- World
- Updated
- 22 Jul 2026
- Source
- European Bank for Reconstruction and Development (EBRD)
ConstructChat
Ask ConstructChat about Pelion Pharma II -Covid-19 response
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | complete |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Provision of emergency short-term liquidity line in the amount of PLN 110 million (c. EUR 24 million) that will allow KIPF ("the company", "client") to actively manage working capital needs across business lines in light of increased sales volatility caused by the Covid-19 outbreak. |
Original sector | Manufacturing and Services |
Budget |
Location
Country | World |
Source
Source | European Bank for Reconstruction and Development (EBRD) |
URL |
More Details
Record type | Project |
Sector | Manufacturing (Industrial), Residential, Commercial, Government |
Article published date | 2025-07-22 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
